Robert Georgantas - Feb 8, 2022 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Chief Scientific Officer
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Robert Georgantas III
Stock symbol
BDSX
Transactions as of
Feb 8, 2022
Transactions value $
$0
Form type
4
Date filed
2/10/2022, 06:08 PM
Previous filing
Mar 18, 2022
Next filing
Mar 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Award $0 +31.5K $0.00 31.5K Feb 8, 2022 Common Stock 31.5K Direct F1, F2
transaction BDSX Restricted Stock Units Award $0 +22.1K $0.00 22.1K Feb 8, 2022 Common Stock 22.1K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F2 These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.
F3 These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.